| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
198,230,000 |
| Market
Cap: |
32.11(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.162 - $0.162 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing therapies to treat the whole eye. Co.'s gene therapy candidate includes: OCU400, which is used for the treatment of nuclear receptor subfamily 2 group E member 3 mutation-associated retinal diseases and centrosomal protein 290 mutation-associated retinal diseases; OCU410, which is being developed for the treatment of dry age-related macular degeneration (AMD); OCU200, which is designed to treat diabetic macular edema, diabetic retinopathy and wet AMD; and OCU300, which is a small molecule therapeutic in clinical development for patients with ocular graft-versus-host disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
200,278 |
200,278 |
| Total Buy Value |
$0 |
$0 |
$99,999 |
$99,999 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
599,809 |
| Total Sell Value |
$0 |
$0 |
$0 |
$1,096,737 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
8 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Zhang Junge |
Director |
– • – |
2019-11-18 |
4 |
B |
$0.41 |
$41,000 |
D/D |
100,000 |
135,078 |
2.39 |
- |
|
| Zhang Junge |
Director |
– • – |
2019-10-11 |
4 |
B |
$1.48 |
$5,920 |
D/D |
4,000 |
35,078 |
2.39 |
- |
|
| Subramanian Sanjay |
Chief Financial Officer |
• – – |
2019-10-02 |
4 |
B |
$1.88 |
$9,400 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Zhang Junge |
Director |
– • – |
2019-09-30 |
4 |
B |
$2.45 |
$96,141 |
D/D |
31,078 |
31,078 |
2.39 |
- |
|
| Potti Manish |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
123,429 |
|
- |
|
| Kompella Uday |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
479,416 |
|
- |
|
| Kompella Uday |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
950,674 |
|
- |
|
| Leo Frank |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
103,122 |
|
- |
|
| Taspolatoglu Suha |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
742,905 |
|
- |
|
| Musunuri Shankar |
Chief Executive OfficerOfficer |
• • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,375,299 |
|
- |
|
| Zhang Junge |
Director |
– • – |
2019-09-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
212,863 |
|
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,648,289 |
5,258,859 |
|
- |
|
| Rakin Kevin |
Director |
– • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
177,777 |
257,846 |
|
- |
|
| Rakin Kevin |
Director |
– • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
173,076 |
418,639 |
|
- |
|
| Lewis Michael |
Director |
– • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,648,289 |
5,258,859 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-01-15 |
4 |
S |
$0.15 |
$51,885 |
I/I |
(345,897) |
1,692,366 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-01-14 |
4 |
S |
$0.16 |
$64,081 |
I/I |
(400,507) |
2,038,263 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-01-11 |
4 |
S |
$0.17 |
$42,806 |
I/I |
(251,800) |
2,438,770 |
|
- |
|
| Lewis Michael |
Director |
– • • |
2018-10-10 |
4 |
B |
$0.00 |
$0 |
I/I |
538,460 |
3,610,570 |
2.17 |
- |
|
| Wilmslow Estates Ltd |
10% Owner |
– – • |
2018-10-10 |
4 |
B |
$0.00 |
$0 |
D/D |
538,460 |
3,610,570 |
2.37 |
- |
|
| Rakin Kevin |
Director |
– • – |
2018-10-10 |
4 |
B |
$0.00 |
$0 |
D/D |
230,768 |
245,563 |
2.31 |
- |
|
| Gridley Adam |
President and CEO |
• • – |
2018-05-16 |
4 |
B |
$2.15 |
$4,300 |
D/D |
2,000 |
7,000 |
2.73 |
- |
|
| Gill David N |
Director |
– • – |
2017-08-16 |
4 |
B |
$1.81 |
$5,439 |
D/D |
3,000 |
14,000 |
2.39 |
- |
|
| Gill David N |
Director |
– • – |
2017-05-16 |
4 |
B |
$1.68 |
$5,040 |
D/D |
3,000 |
11,000 |
2.39 |
- |
|
| Gill David N |
Director |
– • – |
2016-12-15 |
4 |
B |
$1.65 |
$4,950 |
D/D |
3,000 |
8,000 |
2.31 |
- |
|
195 Records found
|
|
Page 6 of 8 |
|
|
